Drug details

Myrbetriq (mirabegron)

type of Beta3 Agonists

Myrbetriq (mirabegron) is a beta-3 adrenergic agonist used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

The drug is often used to treat Urinary incontinence .

This drug may have the following side effects:

• severe headache,
• painful or difficult urination,
• fast or pounding heartbeats,
• pain or burning when you urinate,
• blurred vision, and
• pounding in your neck or ears

The following drugs are related to Myrbetriq, either as a replacement or used together:

• Anturol (oxybutynin)
• Botox (botulinum toxin type a)
• Botox Cosmetic (onabotulinumtoxina for injection)
• Minirin (desmopressin acetate nasal spray)
• Nocdurna (desmopressin acetate sublingual tablets)
• Detrol (tolterodine tartrate)
• Detrol LA (tolterodine tartrate)
• Ditropan (oxybutynin tablets)
• Ditropan XL (oxybutynin chloride extended release tablets)
• Sinequan (doxepin)
• Gelnique (oxybutynin chloride 10 % gel)
• Tofranil (imipramine)
• Tofranil-PM (imipramine pamoate)
• Oxytrol (oxybutynin transdermal)